Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes

Mutation Research - Genetic Toxicology

Volumn 368, Issue 3-4, 1996, Pages 205-211

  Ribas, G ^a   Xamena, N ^a   Creus, A ^a   Marcos, R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Human lymphocyte; SCE assay; Topoisomerase inhibitor

Indexed keywords

AMSACRINE; CAMPTOTHECIN; ETOPOSIDE; GYRASE INHIBITOR; MITOMYCIN C; NALIDIXIC ACID;

ARTICLE; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; NORMAL HUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0030570559     PISSN: 01651218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1218(96)90062-2     Document Type: Article

References (25)

1. Anderson R.D., Berger N.A. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutation Res. 309:1994;109-142.
2. Backer L.C., Allen J.W., Harrington-Brock K., Campbell J.A., DeMarini D.M., Doerr C.L., Howrad D.R., Kligerman A.D., Moore M.M. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro. Mutagenesis. 5:1990;541-547.
3. Baker R.J., Nelder J.A. The GLIM System, Release 3: Generalized Linear Interactive Modelling. 1978;Royal Statistical Society, London.
4. Cooke D., Allen J., Clare M.G., Doré C.J., Henderson L. Statistical methods for sister chromatid exchange experiments. Kirkland D.J. Statistical Evaluation on Mutagenicity Test Data. 1989;155-183 Cambridge University Press, Cambridge.
5. Cortés F., Piñero J., Ortiz T. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases. Mutation Res. 303:1993;71-76.
6. Cortés F., Piñero J. Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells. Cancer Chemother. Pharmacol. 34:1994;411-415.
7. Darroudi F., Natarajan A.T. Cytogenetic characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs5 and xrs6. IV: Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II. Mutation Res. 212:1989;137-148.
8. Degrassi F., De Salvia R., Tanzarella C., Palitti F. Induction of chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian topoisomerase I. Mutation Res. 211:1989;125-130.
9. Dillehay L.E., Jacobson-Kram D., Williams J.R. DNA topoisomerases and models of sister-chromatid exchange. Mutation Res. 215:1989;15-23.
10. Drlica F., Franco R. Inhibitors of DNA topoisomerases. Biochemistry. 27:1988;2253-2259.
11. Holden H.E., Barett J.F., Huntington C.M., Muehlbauer P.A., Wahrenburg M.G. Genetic profile of a nalidixic acid analog: a model for the mechanism of sister chromatid exchange induction. Environ. Mol. Mutagen. 13:1989;238-252.
12. Kowalczyk J. Sister chromatid exchanges in children treated with nalidixic acid. Mutation Res. 77:1980;371-375.
13. Lamberti L., Bigatti Ponzetto P., Ardito G. Cells kinetics and sister-chromatid exchange frequency in human lymphocytes. Mutation Res. 120:1983;193-199.
14. Latt S.A., Allen J., Bloom S.E., Carrano A., Falke E., Kram D., Schneider E., Schreck R., Tice R., Whitfield B., Wolff S. Sister-chromatid exchanges: a report of the Gene-Tox Program. Mutation Res. 87:1981;17-62.
15. Lim M., Liu L.F., Jacobson-Kram D., Williams J.R. Induction of sister chromatid exchanges by inhibitors of topoisomerases. Cell Biol. Toxicol. 2:1986;485-494.
16. Liu L.F., Liu C.C., Alberts B.M. Type II DNA topoisomerases. Enzymes that can unknot a topologically knotted DNA molecule via a reversible double strand break. Cell. 19:1980;697-707.
17. Mailhes J.B., Marchetti F., Phillips G.L. Jr., Barnhill D.R. Preferential pericentric lesions and aneuploidy induced in mouse oocytes by the topoisomerase II inhibitor etoposide. Teratogen. Carcinogen. Mutagen. 14:1994;39-51.
18. Perry P.E., Wolff S. New Giemsa method for the differential satining of sister chromatids. Nature. 251:1974;156-158.
19. Pommier Y., Zwelling L.A., Kao-Shan C.S., Whang-Pen J., Bradley M.O. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations and cytotoxicity in Chinese hamster cells. Cancer Res. 45:1985;3143-3149.
20. Pommier Y., Kerrigan D., Covey J.M., Kao-Shan C-S., Whang-Peng J. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/OHE) Chinese hamster cells. Cancer Res. 48:1988;512-516.
21. Rusquet R., Bonhommet M., David J. Quinolone antibiotics inhibit eukaryotic DNA polymerase and terminal deoxynucleotidyl transferase but not DNA ligase. Biochem. Biophys. Res. Commun. 121:1984;762-769.
22. Shibuya M.L., Ueno A.M., Vannais D.B., Craven P.A., Waldren C.A. Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II. Cancer Res. 54:1994;1092-1097.
23. Stenchever M., Powell W., Jarvis J. Effect of nalidixic acid on human chromosome integrity. Am. J. Obstet. Gynecol. 107:1970;329-330.
24. Sumner A.T. Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis. J. Cell Sci. 103:1992;105-115.
25. Tominaga K., Shinkai T., Saijo N., Nakajima T., Ochi H., Suemasu K. Cytogenetic effects of etoposide (VP-16) on human lymphocytes with special reference to the relation between sister chromatid exchange and chromatid breakage. Jpn. J. Cancer Res. 77:1986;385-391.